[go: up one dir, main page]

FR3039402B1 - Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral - Google Patents

Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral

Info

Publication number
FR3039402B1
FR3039402B1 FR1557321A FR1557321A FR3039402B1 FR 3039402 B1 FR3039402 B1 FR 3039402B1 FR 1557321 A FR1557321 A FR 1557321A FR 1557321 A FR1557321 A FR 1557321A FR 3039402 B1 FR3039402 B1 FR 3039402B1
Authority
FR
France
Prior art keywords
prevention
treatment
intervertebral disc
injection solution
disc degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1557321A
Other languages
English (en)
Other versions
FR3039402A1 (fr
Inventor
Celia Halimi
Laurent David
Eric Viguier
Thierry Delair
Alexandra Montembault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTOSIAL BIOMEDIC
Centre National de la Recherche Scientifique CNRS
Institut Enseignement Superieur et Recherche en Alimentation Sante Animale Sciences Agronomiques et Environnement
Universite Jean Monnet
Universite Claude Bernard Lyon 1
Original Assignee
CYTOSIAL BIOMEDIC
Centre National de la Recherche Scientifique CNRS
Institut Enseignement Superieur et Recherche en Alimentation Sante Animale Sciences Agronomiques et Environnement
Universite Jean Monnet
Universite Claude Bernard Lyon 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CYTOSIAL BIOMEDIC, Centre National de la Recherche Scientifique CNRS, Institut Enseignement Superieur et Recherche en Alimentation Sante Animale Sciences Agronomiques et Environnement, Universite Jean Monnet, Universite Claude Bernard Lyon 1 filed Critical CYTOSIAL BIOMEDIC
Priority to FR1557321A priority Critical patent/FR3039402B1/fr
Publication of FR3039402A1 publication Critical patent/FR3039402A1/fr
Application granted granted Critical
Publication of FR3039402B1 publication Critical patent/FR3039402B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1557321A 2015-07-30 2015-07-30 Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral Active FR3039402B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1557321A FR3039402B1 (fr) 2015-07-30 2015-07-30 Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1557321A FR3039402B1 (fr) 2015-07-30 2015-07-30 Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral

Publications (2)

Publication Number Publication Date
FR3039402A1 FR3039402A1 (fr) 2017-02-03
FR3039402B1 true FR3039402B1 (fr) 2017-08-25

Family

ID=55759654

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1557321A Active FR3039402B1 (fr) 2015-07-30 2015-07-30 Solution aqueuse de chitosane injectable pour la prevention ou le traitement de la degenerescence du disque intervertebral

Country Status (1)

Country Link
FR (1) FR3039402B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115105464B (zh) * 2022-08-31 2022-12-02 山东大学齐鲁医院 一种纳米复合水凝胶及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221370A1 (en) * 2000-11-15 2002-05-27 Bio Syntech Canada Inc Method for restoring a damaged or degenerated intervertebral disc
FR2983070B1 (fr) * 2011-11-30 2014-04-25 Cytosial Biomedic Solution aqueuse homogene de chitosane injectable

Also Published As

Publication number Publication date
FR3039402A1 (fr) 2017-02-03

Similar Documents

Publication Publication Date Title
EP3399923C0 (fr) Système pour le traitement d'une obstruction microvasculaire
IL247111A0 (en) Preventive or therapeutic agent for kidney disease
SI3110418T1 (sl) Arilne, heteroarilne in heterociklične spojine za zdravljenje s komplementom posredovanih motenj
HRP20181130T1 (hr) Postupci za liječenje infekcija virusom filoviridae
MA39748A (fr) Cenicriviroc pour le traitement de la fibrose
EP3324965A4 (fr) Modulateurs de la gamma-sécrétase pour le traitement de dysfonctionnement du système immunitaire
BR112016022062A2 (pt) Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico
IL255185A0 (en) 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
EP3102220C0 (fr) Compositions de complément alimentaire synergique pour la prévention, le traitement ou la régulation de troubles inflammatoires
LT3157531T (lt) Žarnyno enteroendokrininės sistemos stimuliavimo būdai ir kompozicijos, skirtos su ja susijusioms ligoms arba būklėms gydyti
GB201611712D0 (en) Methods and compounds for the treatment or prevention of severe or persistent influenza
EP3341398C0 (fr) Composés destinés à induire une formation de tissu et utilisations de ces composés
IL247116A0 (en) Compositions and methods for treating and preventing macular degeneration
LT3153511T (lt) 2-acilaminotiazolo dariniai, skirti panaudoti šlapimo pūslės/šlapimo takų ligų prevencijai arba gydymui
IL252431B (en) 15-hepe or a composition comprising 15-hepe for treating or preventing fibrosis
EP3493823C0 (fr) Composé à base de postbiotique pour le traitement de l'inflammation oculaire
EP3329929A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de la sécheresse oculaire
EP3352684C0 (fr) Système pour le traitement d'une épistaxis
MA40687A (fr) Méthodes et compositions de traitement de malformation vasculaire
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
ES2894844T8 (es) Tratamiento de la calcificación vascular
EP3511011A4 (fr) Composition pour prévenir ou améliorer la fatigue oculaire
FR3022139B1 (fr) Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
EP3626256C0 (fr) Composition pour le traitement des lésions tissulaires

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170203

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11